Haematopoiesis is maintained by a hierarchical system where haematopoietic stem cells (HSCs) give rise to multipotent progenitors, which in turn differentiate into all types of mature blood cells 1 . HSCs maintain themselves for the lifetime of the organism because of their ability to self-renew. However, multipotent progenitors lack the ability to self-renew, therefore their mitotic capacity and expansion potential are limited and they are destined to eventually stop proliferating after a finite number of cell divisions 1,2 . The molecular mechanisms that limit the proliferation capacity of multipotent progenitors and other more mature progenitors are not fully understood 2, 3 . Here we show that bone marrow cells from mice deficient in three genes genetically downstream of Bmi1-p16 Ink4a , p19 Arf and Trp53 (triple mutant mice; p16 Ink4a and p19 Arf are alternative reading frames of the same gene (also called Cdkn2a) that encode different proteins)-have an approximately 10-fold increase in cells able to reconstitute the blood long term. This increase is associated with the acquisition of long-term reconstitution capacity by cells of the phenotype c-kit
CD48
2 Lin 2 , which defines multipotent progenitors in wild-type mice [4] [5] [6] . The pattern of triple mutant multipotent progenitor response to growth factors resembles that of wild-type multipotent progenitors but not wild-type HSCs. These results demonstrate that p16 Ink4a /p19 Arf and Trp53 have a central role in limiting the expansion potential of multipotent progenitors. These pathways are commonly repressed in cancer, suggesting a mechanism by which early progenitor cells could gain the ability to self-renew and become malignant with further oncogenic mutations.
Bmi1 is necessary for the maintenance of adult HSCs and neural stem cells [7] [8] [9] .The p16 Ink4a /p19 Arf locus is one of the major targets repressed by Bmi1 (refs 8, 10) . In neural stem cells, p16
Ink4a or p19
Arf deficiency partially restored the ability of Bmi1-deficient stem cells to self-renew 7, 11 . We analysed the effect of individually deleting either p16 Ink4a , p19 Arf or Trp53 in Bmi1-deficient mice and found that in the blood system, Trp53 deficiency, but not p19
Arf or p16
Ink4a deficiency, partially rescues Bmi1 2/2 HSCs (Supplementary Figs 2  and 3 and Supplementary Table 1) .
Because the deletion of either the p16 Ink4a /p19 Arf locus 12 or Trp53 seems to have a role in the rescue of HSCs in Bmi1-deficient mice, we examined the impact of deleting p19
Arf , p16 Ink4a /p19 Arf , Trp53 and p16 Ink4a /p19 Arf /Trp53 on the mature cells of the haematopoietic system. Analysis of the liver, spleen, bone marrow and peripheral blood from mutant mice showed no defects in the output of mature cells (Supplementary Figs 4 and 5) . Neutrophil, lymphocyte and monocyte counts from mutant mice were normal ( Supplementary Fig. 4 ), as were haematocrit and platelet counts (data not shown). In the bone marrow of mutant mice, levels of B220 Supplementary Fig. 4 ). Analysis of spleen and thymus also showed normal levels of mature haematopoietic cells ( Supplementary Fig. 4) Ink4a and p19 Arf does not significantly affect the long-term reconstitution frequency of HSCs and has more of an effect in the context of stem-cell ageing [13] [14] [15] . Notably, the frequency of long-term reconstituting cells in triple mutant bone marrow was at least 10-fold higher than that of wild-type bone marrow (Table 1) .
Our results suggest that triple deletion of p16 Ink4a , p19 Arf and Trp53 caused a striking increase in the frequency of long-term bloodrepopulating cells. We therefore decided to examine further the bone marrow of triple mutant mice. Because there was only a modest increase in the frequency of bone marrow cells with a phenotype of HSCs in triple mutant mice (Fig. 1a, b) , we concluded that the increased repopulating activity in the triple mutant mice was probably not due to the expansion of the overall numbers of HSCs but rather to acquisition of stem-cell-like properties by other cells. Therefore, we compared the long-term reconstitution capacity of both HSCs (defined as CD150
) and multipotent progenitors (defined as Sca-1
Lin 2 ) from wild-type and triple mutant mice. We performed two independent experiments where we injected either 100 or 500 HSCs or multipotent progenitors from four different triple mutant mice into lethally irradiated recipients along with a radioprotective dose of recipient-type bone marrow. Contribution to the generation of lymphocytes, monocytes and granulocytes after 12 weeks is an indicator of long-term reconstitution 1 . Consistent with previous reports 4, 16, 17 , wild-type HSCs, but not multipotent progenitors, contributed to the long-term generation of monocytes and granulocytes (Fig. 2a, c) . Recipient mice injected with HSCs from the bone marrow of triple mutant mice showed long-term reconstitution for multiple lineages ( Fig. 2b and Supplementary Table 3) . Notably, recipient mice injected with multipotent progenitors from each of the four triple mutant mice were also long-term multi-lineage reconstituted ( Fig. 2d and Supplementary Table 3 ). Contribution to haematopoiesis was observed at 14 to 20 weeks (Fig. 2b, d 
Trp53
2/2 bone marrow compared to wild-type marrow (Fig. 1a, b) . We also used Flt3, which is expressed by normal multipotent progenitors but not HSCs, as an alternative marker to distinguish HSCs from multipotent progenitors 5, 6 . We found that the wild-type and triple mutant Sca-1 1 c-kit
2 Lin 2 cells expressed higher levels of this marker than did cells with a stem cell phenotype of CD150 Fig. 1c) . This further suggests that the phenotype of HSCs and multipotent progenitors is not altered in the triple mutant mice.
Next, we performed three independent in vitro proliferation experiments to provide evidence that triple mutant CD150
2 Lin 2 cells were indeed multipotent progenitors and to understand the mechanisms by which their lifespan was extended. We used culture conditions that allow HSCs to expand in vitro in StemSpan serum-free media containing the growth factors SCF, TPO, IGF-2, FGF-1 and Angptl3 (STIFA media) [18] [19] [20] . When cultured in STIFA medium, wild-type multipotent progenitors proliferated fivefold less than wild-type HSCs (Fig. 3a) , and the addition of Flt3 ligand to the media doubled the proliferative rate of the multipotent progenitors (Fig. 3a) . Notably, when cultured in STIFA media, triple mutant multipotent progenitors also proliferated about fivefold less than triple mutant HSCs and still responded to Flt3 ligand (Fig. 3a) . This suggests that triple mutant multipotent progenitors, although capable of long-term reconstitution, display an in vitro functional behaviour that mirrors that of wild-type multipotent progenitors and are different from HSCs. In two independent experiments we also determined the percentage of cells undergoing apoptosis in STIFA media in the case of HSCs and STIFA media plus Flt3 ligand for multipotent progenitors, measured by annexin V staining. Triple mutant HSCs and multipotent progenitors had threefold and twofold decreases, respectively, in the percentage of cells undergoing apoptosis compared to wild-type cells (Supplementary Fig. 9 ). The proliferation advantage of triple mutant HSCs and multipotent progenitors could be partly due to a decrease in the rate of apoptosis in the triple mutants compared to their wild-type counterparts.
To examine further the proliferative capacity of wild-type and triple mutant HSCs and multipotent progenitors we observed the colony-forming capacity of single cells double-sorted into 96-well plates in Methocult GF M3434 media (Methocult) and Methocult GF M3434 media supplemented with interleukin (IL)-11, granulocyte-macrophage colony-stimulating factor (GM-CSF), TPO and Flt3 ligand (Methocult plus) (Fig. 3b) in three independent experiments. Triple mutant HSCs formed more secondary colonies than wild-type HSCs in Methocult plus media, whereas the triple mutant multipotent progenitors formed significantly more colonies than wild-type multipotent progenitors in both Methocult plus and Methocult media (Fig. 3b) . This clearly shows that triple mutant multipotent progenitors have an enhanced proliferative capacity, and in the Methocult plus media they proliferate and form secondary colonies better than even wild-type HSCs (Fig. 3b, c) .
We next asked whether loss of the p16 Ink4a /p19 Arf and Trp53 loci conferred long-term reconstituting ability on all proliferating blood cells. To do this, we transplanted three recipient mice with 100 c-kit 
Sca-1
2 Lin 2 myeloid progenitors, a more differentiated progenitor population. We could not detect contribution to mature lineages at 4 weeks and 10 weeks, and we stopped analysis at 16 weeks (Fig. 2e) . Next, we transplanted eight recipient mice with 500 or 1,000 triple mutant common myeloid progenitors and another eight recipient mice with 500 or 1,000 granulocyte-macrophage progenitors 21 . After 3 weeks, we were unable to detect mature myeloid cells that were descended from the transplanted common myeloid progenitors or granulocyte-macrophage progenitors (Supplementary Table 3 ). These results suggest that as progenitor cells mature the constraints on self-renewal increase (Supplementary Fig. 1 ).
The cellular hierarchy seen in many tissues with self-renewing stem cells and short-lived progenitors probably evolved to limit the number of cells that can accumulate oncogenic mutations. Our data demonstrates that loss of both p16
Ink4a /p19 Arf and Trp53 loci results in substantial expansion of self-renewing cells. Our results suggest that triple mutant multipotent progenitors have acquired long-term reconstituting ability, implying that the compound deletion of p16 Ink4 , p19 Arf and Trp53 removes constraints limiting self-renewal in early progenitors 2 . However, triple mutant common myeloid progenitors and granulocyte-macrophage progenitors, more differentiated progenitor cells, still have limited lifespans ( Supplementary  Fig. 1 ), suggesting that there must be other genetic pathways that also prevent self-renewal in mature progenitors. This further supports the notion that there are multiple genetic determinants that regulate the frequency of self-renewing haematopoietic cells in vivo 3 . This expansion of long-lived cells potentially reveals a cellular mechanism by which these genes contribute to oncogenesis and may explain why they, or other components of their regulatory pathways, are so commonly mutated or dysregulated in multiple tumour types [22] [23] [24] [25] [26] . The regulation of self-renewal in wild-type HSCs by epigenetically repressing the p16 Ink4a /p19 Arf locus and Trp53 pathway, in contrast to that of triple mutant multipotent progenitors achieved by genetic deficiency of the p16 Ink4a /p19 Arf locus and Trp53, hints at differences in the regulation of self-renewal in normal cells and self-renewing cancer cells that harbour mutations in these genes. Such differences could be exploited as therapeutic targets.
METHODS SUMMARY
Flow cytometry. Isolation and analysis of bone marrow, thymus, spleen and peripheral blood have been previously described 4, 6, 21 and additional details can be found in Methods. Cell proliferation, apoptosis and colony formation. Proliferation of HSCs was assayed via in vitro culture in STIFA expansion media 20 and in the case of multipotent progenitors in STIFA media with or without Flt3 ligand. Apoptosis during in vitro expansion of HSCs and multipotent progenitors was assayed by annexin V and 4,6-diamidino-2-phenylindole (DAPI) staining. Colony formation was performed as previously described 27 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
